PGX has an asymmetric return profile. Moves to the upside are capped, whereas it participates fully in selloffs. While the preferred shares that PGX owns are structurally senior to common equity, debt ...

Pharmacogenomics – testing a patient’s genetic makeup to guide safer, more effective medication choices and dosing – is not a new concept. But, like so many other clinical innovations, adoption has ...

I don't know about you, but any time I spend on LinkedIn, I am then immediately drowned by AI talk by those who are replacing entire companies with AI and how quickly people can build AI. All of that ...

FoundationOne PGx includes genes associated with the metabolism of medicines that have strong clinical evidence and actionable guidelines, including DPYD Foundation Medicine, Inc., a global, ...